Nitric oxide and its derivatives have been shown to both activate and inhib
it prostaglandin H-2 synthase 1 (PGHS-1), We set out to determine the mecha
nisms by which different nitrogen oxide derivatives modulate PGHS-1 activit
y. To this end, we show that 3-morpholinosydnonimine hydrochloride (SIN-1),
a compound capable of generating peroxynitrite, activates purified PGHS-1
and also stimulates PGE(2) production in arterial smooth muscle cells in th
e presence of exogenous arachidonic acid. The effect of SIN-1 in smooth mus
cle cells was abrogated by superoxide and peroxynitrite inhibitors, which s
upports the hypothesis that peroxynitrite is an activating species of PGHS-
1. Indeed, authentic peroxynitrite also induced PGE(2) production in arachi
donic acid-stimulated cells. In contrast, when cells were exposed to the ni
tric oxide-releasing compound 1-hydroxy-2-oxo-3-[(methylamino)propyl]-3-met
hyl-1-triazene (NOC-7), PGHS-1 enzyme activity was inhibited in the presenc
e of exogenous arachidonic acid. Finally, in lipid-loaded smooth muscle cel
ls, we demonstrate that SIN-1 stimulates arachidonic acid-induced PGE(2) pr
oduction; albeit, the extent of activation is reduced compared to that unde
r normal conditions. These results indicate that formation of peroxynitrite
is a key intermediary step in PGHS-1 activation. However, other forms of N
Ox inhibit PGHS-1. These results may have implications in the regulation of
vascular function and tone in normal and atherosclerotic arteries.